Clincosm LogoSign in Get a demo

mpn (myeloproliferative neoplasms)

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MPN (Myeloproliferative Tumors) Trial in Worldwide (Pemigatinib)

Active, not recruiting
  • MPN (Myeloproliferative Neoplasms)
  • Phoenix, Arizona
  • +32 more
Jun 24, 2022

Study (MOST)

Completed
  • MPN (Myeloproliferative Neoplasms)
    • Huntsville, Alabama
    • +115 more
    May 11, 2022

    MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib, Anagrelide, Placebo)

    Terminated
    Has Results
    • MPN (Myeloproliferative Neoplasms)
    • Phoenix, Arizona
    • +25 more
    Oct 21, 2021

    MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (itacitinib)

    Completed
    • MPN (Myeloproliferative Neoplasms)
    • Birmingham, Alabama
    • +21 more
    Aug 25, 2021

    Polycythemia Vera In US Clinical Practices (REVEAL)

    Completed
    • MPN (Myeloproliferative Neoplasms)
      • Green Valley, Arizona
      • +265 more
      Apr 22, 2021

      MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib)

      Completed
      Has Results
      • MPN (Myeloproliferative Neoplasms)
      • Birmingham, Alabama
      • +37 more
      Jan 17, 2020

      MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (Ruxolitinib, Placebo)

      Completed
      Has Results
      • MPN (Myeloproliferative Neoplasms)
      • Birmingham, Alabama
      • +111 more
      Feb 12, 2018